Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SMS Pharmaceuticals Limited ( (IN:SMSPHARMA) ) has issued an announcement.
SMS Pharmaceuticals Limited reported a strong financial performance for the quarter ended June 30, 2025, with a 24% year-on-year increase in Profit After Tax (PAT) and a 19% rise in revenue, driven by higher volumes. The company has also initiated backward integration for key APIs and plans to double its R&D investment over the next 18 months to accelerate pipeline development, alongside a ₹250 crore capital expenditure plan, indicating a robust growth strategy.
More about SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is a diversified and integrated pharmaceutical company specializing in Active Pharmaceutical Ingredients (API) and complex Intermediates for global customers.
Average Trading Volume: 8,022
Technical Sentiment Signal: Buy
Current Market Cap: 19.85B INR
For detailed information about SMSPHARMA stock, go to TipRanks’ Stock Analysis page.